Latest Dilution News

Page 137 of 232
RLF AgTech has completed a $4.5 million placement by issuing over 90 million new shares, bolstering its capacity to advance sustainable crop nutrition solutions across Australia and Asia.
Ada Torres
Ada Torres
1 Sept 2025
Lumos Diagnostics, backed by BARDA, is set to begin a pivotal pediatric clinical study to extend the use of its rapid respiratory infection test, FebriDx, to children aged 2–12 in U.S. CLIA-waived settings, potentially unlocking a $1 billion market.
Ada Torres
Ada Torres
1 Sept 2025
Horizon Gold has successfully completed its renounceable entitlement issue, raising nearly $7 million including a full shortfall placement, positioning the company for further development at its Gum Creek Gold Project.
Maxwell Dee
Maxwell Dee
1 Sept 2025
Warriedar Resources has secured a crucial ASX waiver allowing the cancellation of 5 million unlisted options without shareholder approval, smoothing the path for Capricorn Metals’ acquisition scheme.
Maxwell Dee
Maxwell Dee
1 Sept 2025
Hartshead Resources has struck a pivotal Well Carry Agreement with RockRose Energy, securing full funding for its Phase C drilling costs while trimming its joint venture stake. The move also triggers a licence extension application amid UK regulatory delays.
Maxwell Dee
Maxwell Dee
1 Sept 2025
RPMGlobal has received a $5.00 per share indicative offer from Caterpillar, valuing the mining software firm at over $1.1 billion. The company has agreed to a six-week exclusivity period to negotiate a binding deal.
Sophie Babbage
Sophie Babbage
1 Sept 2025
Opthea Limited reported a 26% reduction in net loss for FY2025 despite discontinuing its wet AMD drug after failed Phase III trials. The company settled its Development Funding Agreement with investors, securing liquidity and planning a strategic pivot.
Ada Torres
Ada Torres
29 Aug 2025
Rewardle Holdings reports a sharp 497% increase in half-year losses amid strategic investments in its MedTech partner CloudHolter and fintech expansions. Despite financial headwinds, the company advances its B2B2C platform with a focus on growth and innovation.
Sophie Babbage
Sophie Babbage
29 Aug 2025
Osteopore Limited reported a 6% increase in revenue to $1.56 million for the half-year ended June 2025, alongside a slight rise in net loss driven by expanded product development and compliance costs. The company secured key regulatory approvals and broadened its distribution footprint in Asia and the US.
Ada Torres
Ada Torres
29 Aug 2025
Beonic Ltd reported a significantly reduced net loss of $3.17 million for FY2025, alongside improved margins and EBITDA profitability, underpinned by a major North African airport contract and a $4.18 million convertible note raise to accelerate growth.
Sophie Babbage
Sophie Babbage
29 Aug 2025
Genmin Limited has increased insider loans by A$0.5 million, reinforcing funding for its flagship Baniaka iron ore project in Gabon as it targets production in late 2026.
Maxwell Dee
Maxwell Dee
29 Aug 2025
Chimeric Therapeutics reported a reduced net loss of $10.43 million for FY2025, driven by cost efficiencies and strategic project reprioritisation, while making significant clinical progress in its CAR T-cell and NK cell therapy programs.
Ada Torres
Ada Torres
29 Aug 2025